Transcriptomics

Dataset Information

0

Novel drug-like RAR-Beta agonist induces BRCA1 to prevent neuropathic pain


ABSTRACT: Neuropathic pain (NP) is associated with profound gene expression alterations within the nociceptive system. DNA mechanisms, such as epigenetic remodelling and repair pathways have been implicated in NP. Here we have used a rat model of peripheral nerve injury to study the effect of a novel RARβ-agonist, C286, currently under clinical research, in NP. A four week treatment initiated two days after the injury normalised pain sensation. Genome-wide and pathway enrichment analysis showed that multiple mechanisms persistently altered in the spinal cord were restored to preinjury levels by the agonist. Concomitant upregulation of DNA repair proteins, ATM and BRCA1, the latter being required for C286 mediated pain modulation, suggest that early DNA repair may be important to prevent phenotypic epigenetic imprints in NP. Thus, C286 is a promising drug candidate for neuropathic pain and DNA repair mechanisms may be useful therapeutic targets to explore.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE135080 | GEO | 2019/09/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-02-14 | GSE145226 | GEO
2020-02-13 | GSE145199 | GEO
2010-01-30 | E-GEOD-15041 | biostudies-arrayexpress
2023-03-15 | GSE212311 | GEO
2016-11-05 | GSE89289 | GEO
2024-09-01 | GSE256472 | GEO
2023-05-05 | GSE217932 | GEO
2009-12-18 | GSE15041 | GEO
2022-03-10 | GSE198020 | GEO
| PRJNA557358 | ENA